PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2017

Jun 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2017-06-12

Reporting Person: WILSON TROY EDWARD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-12	Stock Option (Right to Buy)	$79.20	A	7604	Acquired	2027-06-11	Common Stock (7604)	Direct

Footnotes

F1: The option vests in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.